About
Neurosteer has developed a solution designed for early detection and more effective treatment of a variety of neurological disorders. Its platform consists of a medical-grade wearable device and a cloud-based system that provide real-time monitoring and assessment of brain activity. The companys current focus is on delivering objective biomarkers to identify the early onset of Parkinsons disease, Alzheimers disease, dementia, and epilepsy. Neurosteer uses an adhesive forehead strip connected to a pocket-sized device that wirelessly transmits sensor data to the cloud for proprietary signal processing. Advanced algorithms then decompose the single EEG channel into over 100 individual components for real-time analysis and display on a web-based dashboard. The results are more affordable screening, continuous patient monitoring, and optimized neurostimulation and drug selection, leading to improved neurological treatment and clinical trial outcomes.
Funding history · 1 round · $2.6M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Neurosteer's primary focus in neurological disorder detection?
- Neurosteer's current focus is on delivering objective biomarkers for the early identification of Parkinson's disease, Alzheimer's disease, dementia, and epilepsy.
- When was Neurosteer founded?
- Neurosteer was founded in August 2015.
- What type of funding did Neurosteer receive in September 2015?
- In September 2015, Neurosteer received Seed funding from investor Arkady Volozh. For full financing history, please refer to startupim.
- What grant did Neurosteer receive in June 2018?
- In June 2018, Neurosteer received a grant of $58,400 from the IIA.
- How many employees does Neurosteer currently have?
- Neurosteer currently has 12 employees.
- What is the core technology behind Neurosteer's platform?
- Neurosteer's platform uses an adhesive forehead strip connected to a pocket-sized device that wirelessly transmits sensor data to the cloud for proprietary signal processing and analysis, decomposing a single EEG channel into over 100 individual components.
- Where is Neurosteer's headquarters located?
- Neurosteer's headquarters is located in Herzliya, Israel.
- What is the product stage of Neurosteer's solution?
- Neurosteer's product is in the clinical trial stage.
- What was a notable news event for Neurosteer in March 2020?
- In March 2020, Neurosteer was reported by blogs.timesofisrael.com for pursuing a wearable device to detect Alzheimer's.